FIG 7.
Generation and characterization of artificially recombinant PRRSVs. (A) Schematic diagram for constructing recombinant plasmids. (B) Virus detection by immunofluorescence. Recombinant and parental plasmids (4 μg) were transfected into Marc-145 cells. At 5 days posttransfection, the transfected cells were fixed and stained with monoclonal antibody 3F7 against PRRSV, followed by incubation with Alexa Fluor 488-conjugated goat anti-mouse IgG. Scale bar, 400 μm. The growth kinetics of the recombinant (rHeB108-HuN4NSP9 and rHeB108-HuN4NSP9p) and parental viruses in PAMs (C and D) and Marc-145 cells (E and F) are represented. Each data point represents the mean value of three replicates with the SD. *, Significant difference between rHeB108 and rHeB108-HuN4NSP9 (*, P < 0.05; **, P < 0.01; ***, P < 0.001); #, significant difference between rHeB108 and rHeB108-HuN4NSP9p (#, P < 0.05; ##, P < 0.01; ###, P < 0.001); δ, significant difference between rHuN4 and rHeB108-HuN4NSP9 (δ, P < 0.05; δδ, P < 0.01; δδδ, P < 0.001); ψ, significant difference between rHuN4 and rHeB108-HuN4NSP9p (ψ, P < 0.05; ψψ, P < 0.01; ψψψ, P < 0.001).